FeesSafety
Pluang+

TriplePoint Venture Growth BDC faces severe payout coverage issues with cash income covering only 40% next year.

Market News
10 Nov 2026, 17:17 WIB
Seeking Alpha
View Source
Bearish
TriplePoint Venture Growth BDC faces severe payout coverage issues with cash income covering only 40% next year.

TriplePoint Venture Growth BDC Corp. is struggling with distribution coverage as its cash net investment income (NII) will cover only about 40% of its payout next year. The company's portfolio quality is declining, and asset sales are being used to fund distributions. Additionally, refinancing $125 million in 2027 notes amid rising interest rates will further pressure NII. Despite these financial challenges, management is unlikely to reduce the distribution, posing risks to investors.

TriplePoint Venture Growth's distribution challenges provide context for financial sector activity on Pluang. For readers following Financials as of Nov 10, 2026 21:21 WIB: out of 142 priced US stocks, 76 rose and 56 fell. Notable movers include HUT at USD 55.21 with a 3.17% decline and 72% sell order activity, WULF at USD 11.99 down 3.11% with 78% buy orders, and CRCL at USD 65.51 down 3.03% with 60% buy orders. Typical hold times range from 12 to 23 days among these stocks.

More News

Science 37 named BioSpace 2027 Best Place to Work for innovative clinical trial model and culture

Science 37 named BioSpace 2027 Best Place to Work for innovative clinical trial model and culture

Science 37, a direct-to-patient clinical research site, was named a BioSpace 2027 Best Place to Work, recognized for its innovative culture and commitment to clinical quality. The company’s model brings clinical trials to patients' homes, improving a...

Others
Bullish
1 hour ago
Peptide therapeutics market to hit $229B by 2036, driven by GLP-1, oncology, and generics growth

Peptide therapeutics market to hit $229B by 2036, driven by GLP-1, oncology, and generics growth

The global peptide therapeutics market is projected to grow from $112.2 billion in 2026 to $229.32 billion by 2036, at a CAGR of 7.4%. Growth is fueled by expanding use of GLP-1 and incretin therapies, advances in peptide engineering, new oncology ap...

Bullish
1 hour ago
New AI tool Book Leopard cuts Amazon book marketing costs to under $50 with fast, quality covers and ads.

New AI tool Book Leopard cuts Amazon book marketing costs to under $50 with fast, quality covers and ads.

Book Leopard, a new AI software, enables authors and publishers to create professional-quality Amazon book marketing materials in seconds for a one-time fee of $49, drastically reducing costs from over $1,000 and weeks of waiting. The tool generates ...

Others
Bullish
2 hours ago
Global nucleic acid labeling market to hit $2.8B by 2032, driven by genomics and diagnostics growth.

Global nucleic acid labeling market to hit $2.8B by 2032, driven by genomics and diagnostics growth.

The global nucleic acid labeling market, valued at $1.7 billion in 2025, is projected to grow to $2.8 billion by 2032 at a 7% CAGR. Growth is fueled by advances in genomics, molecular diagnostics, and personalized medicine, with increasing demand for...

Market News
Bullish
2 hours ago
MonetizeMore launches AI tool to help publishers avoid Google AdSense bans.

MonetizeMore launches AI tool to help publishers avoid Google AdSense bans.

MonetizeMore introduced the AdSense Policy Grader, an AI-powered tool that audits websites for compliance with Google's ad policies to prevent account bans and revenue loss. The tool offers a free basic report and a detailed paid report covering 79 p...

Others
Neutral
2 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App